Ces radiol. 2017, 71(4):323-330 | DOI: 10.55095/CesRadiol2017/044

Molecular imaging by magnetic resonanceReview article

Daniel Jirák
MR oddělení, Pracoviště radiodiagnostiky a intervenční radiologie, Institut klinické a experimentální medicíny, Praha

We describe the history of molecular/cellular imaging using magnetic resonance imaging in the Czech Republic, our experience gained at the Department of Magnetic Resonance at the Institute for Clinical and Experimental Medicine and the latest trends in this field, including the use of multimodal contrast agents. The article also contains applications from experimental medicine on various animal models and an example of a clinical study using contrast agents to label transplanted pancreatic islets.

Keywords: contrast agent, cell labeling, molecular imaging, animal models, clinical trial
Grants and funding:

Podpořeno z programového projektu Ministerstva zdravotnictví ČR s reg. č. 15-25781A a MZ ČR - RVO ("Institut klinické a experimentální medicíny - IKEM, IČ 00023001") a GAČR P205-16-03156S.

Accepted: November 15, 2017; Published: December 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jirák D. Molecular imaging by magnetic resonance. Ces radiol. 2017;71(4):323-330. doi: 10.55095/CesRadiol2017/044.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jendelova P, Herynek V, DeCroos J, Glogarova K, Andersson B, Hajek M, et al. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn Reson Med 2003; 50(4): 767-776. Go to original source... Go to PubMed...
    2. Jendelova P, Herynek V, Urdzikova L, Glogarova K, Kroupova J, Andersson B, et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 2004; 76(2): 232-243. Go to original source... Go to PubMed...
    3. Jirak D, Kriz J, Herynek V, Andersson B, Girman P, Burian M, et al. MRI of transplanted pancreatic islets. Magn Reson Med 2004; 52(6): 1228-1233. Go to original source... Go to PubMed...
    4. Seppenwoolde JH, Viergever MA, Bakker CJ. Passive tracking exploiting local signal conservation: the white marker phenomenon. Magn Reson Med 2003; 50(4): 784-790. Go to original source... Go to PubMed...
    5. Cunningham CH, Arai T, Yang PC, McConnell MV, Pauly JM, Conolly SM. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn Reson Med 2005; 53(5): 999-1005. Go to original source... Go to PubMed...
    6. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 2006; 55(1): 126-135. Go to original source... Go to PubMed...
    7. Stuber M, Gilson WD, Schar M, Kedziorek DA, Hofmann LV, Shah S, et al. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-resonant water suppression (IRON). Magn Reson Med 2007; 58(5): 1072-1077. Go to original source... Go to PubMed...
    8. Patil S, Bieri O, Scheffler K. Echo-dephased steady state free precession. MAGMA 2009; 22(5): 277-285. Go to original source... Go to PubMed...
    9. Robson MD, Gatehouse PD, Bydder M, Bydder GM. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J Comput Assist Tomogr 2003; 27(6): 825-846. Go to original source... Go to PubMed...
    10. Zhang L, Zhong X, Wang L, Chen H, Wang YA, Yeh J, et al. T(1)-weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles. J Magn Reson Imaging 2011; 33(1): 194-202. Go to original source... Go to PubMed...
    11. Holmes JEBGM. MR imaging with ultrashort TE (UTE) pulse sequences: Basic principles. Radiography 2005; 11(3): 163-174. Go to original source...
    12. Helfer BM, Balducci A, Nelson AD, Janjic JM, Gil RR, Kalinski P, et al. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. Cytotherapy 2010; 12(2): 238-250. Go to original source... Go to PubMed...
    13. Ahrens ET, Flores R, Xu H, Morel PA. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005; 23(8): 983-987. Go to original source... Go to PubMed...
    14. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET. Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 2007; 58(4): 725-734. Go to original source... Go to PubMed...
    15. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000; 143(1): 79-87. Go to original source... Go to PubMed...
    16. Hoffman AS. The origins and evolution of "controlled" drug delivery systems. J Control Release 2008; 132(3): 153-163. Go to original source... Go to PubMed...
    17. Talelli M, Rijcken CJ, van Nostrum CF, Storm G, Hennink WE. Micelles based on HPMA copolymers. Adv Drug Deliv Rev 2010; 62(2): 231-239. Go to original source... Go to PubMed...
    18. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010; 21(5): 797-802. Go to original source... Go to PubMed...
    19. Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008; 14(5): 1310-1316. Go to original source... Go to PubMed...
    20. Soenen SJ, Brisson AR, Jonckheere E, Nuytten N, Tan S, Himmelreich U, et al. The labeling of cationic iron oxide nanoparticle-resistant hepatocellular carcinoma cells using targeted magnetoliposomes. Biomaterials 2011; 32(6): 1748-1758. Go to original source... Go to PubMed...
    21. Matthew E, Laskin JD, Zimmerman EA, Weinstein IB, Hsu KC, Engelhardt DL. Benzodiazepines have high-affinity binding sites and induce melanogenesis in B16/C3 melanoma cells. Proc Natl Acad Sci USA 1981; 78(6): 3935-3939. Go to original source... Go to PubMed...
    22. Oppitz M, Busch C, Garbe C, Drews U. Distribution of muscarinic receptor subtype M3 in melanomas and their metastases. J Cutan Pathol 2008; 35(9): 809-815. Go to original source... Go to PubMed...
    23. Trounson A, McDonald C. Stem Cell Therapies in Clinical Trials: Progress and Challenges. Cell Stem Cell 2015; 17(1): 11-22. Go to original source... Go to PubMed...
    24. Toso C, Vallee JP, Morel P, Ris F, Demuylder-Mischler S, Lepetit-Coiffe M, et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant 2008; 8(3): 701-706. Go to original source... Go to PubMed...
    25. Saudek F, Jirak D, Girman P, Herynek V, Dezortova M, Kriz J, et al. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation 2010; 90(12): 1602-1606. Go to original source... Go to PubMed...
    26. Malosio ML, Esposito A, Brigatti C, Palmisano A, Piemonti L, Nano R, et al. MR imaging monitoring of iron-labeled pancreatic islets in a small series of patients: islet fate in successful, unsuccessful, and autotransplantation. Cell Transplant 2015; 24(11): 2285-2296. Go to original source... Go to PubMed...
    27. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51(1): 66-72. Go to original source... Go to PubMed...
    28. Barshes NR, Wyllie S, Goss JA. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts. J Leukoc Biol 2005; 77(5): 587-597. Go to original source... Go to PubMed...
    29. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45(9): 1161-1167. Go to original source... Go to PubMed...
    30. Gálisová A, Jirák D, Krchová T, Herynek V, Fábryová E, Kotek J, et al. Magnetic resonance visualization of pancreatic islets labeled by PARACEST contrast agents at 4.7 T. J Mol Imag Dynamic 2016; 6(121). Go to original source...
    31. Aasen SN, Pospisilova A, Eichler TW, Panek J, Hruby M, Stepanek P, et al. A novel nanoprobe for multimodal imaging is effectively incorporated into human melanoma metastatic cell lines. Int J Mol Sci 2015; 16(9): 21658-21680. Go to original source... Go to PubMed...
    32. Herynek V, Berkova Z, Dovolilova E, Jirak D, Kriz J, Girman P, et al. Improved detection of pancreatic islets in vivo using double contrast. Contrast Media Mol Imaging 2011; 6(4): 308-313. Go to original source... Go to PubMed...
    33. Jirak D, Kriz J, Strzelecki M, Yang J, Hasilo C, White DJ, et al. Monitoring the survival of islet transplants by MRI using a novel technique for their automated detection and quantification. MAGMA 2009; 22(4): 257-265. Go to original source... Go to PubMed...
    34. Kriz J, Jirak D, Berkova Z, Herynek V, Lodererova A, Girman P, et al. Detection of pancreatic islet allograft impairment in advance of functional failure using magnetic resonance imaging. Transpl Int 2012; 25(2): 250-260. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content